Angelica Brandelius
Dr. Angelica Brandelius, MD, PhD, is a licensed physician and certified medical trainer with a background in immunology, clinical research and more than 15 years of experience in exercise and health. At Yazen, she develops digital solutions that help people build and maintain an active lifestyle.
Saxenda (liraglutide) in the treatment of obesity
Saxenda is a medicine used as support in the treatment of overweight and obesity. It contains the active substance liraglutide, which influences appetite regulation and helps reduce energy intake. When combined with lifestyle changes such as a healthy diet and regular physical activity, the treatment can support clinically significant weight loss (1).
Rybelsus (semaglutide) in the treatment of obesity
Rybelsus is a medicine containing the active substance semaglutide. It is approved for the treatment of adults with type 2 diabetes to improve glycaemic control as a complement to a healthy diet and physical activity.
The treatment may also contribute to weight loss (1,2).
Mounjaro (tirzepatide) in the treatment of obesity
Mounjaro is a medicine that can help people living with type 2 diabetes – as well as those with overweight or obesity – to regulate blood sugar, improve their health and achieve sustainable weight loss. To make an informed decision about treatment, it is important to understand how Mounjaro works, who it is suitable for, and how it can support long-term lifestyle change.
Ozempic (semaglutide) in the treatment of obesity
Ozempic is a prescription medicine containing semaglutide as its active substance. This medicine was originally approved for the treatment of type 2 diabetes, but has since also been shown to contribute to clinically significant weight loss. Semaglutide has demonstrated significant improvements in body weight and metabolic markers in studies involving individuals with overweight or obesity. To make an informed decision about treatment, it is important that the person receives accurate information about how Ozempic works, who it is suitable for, and how it may affect long-term health (1,2).
Wegovy (semaglutide) in the treatment of obesity
Wegovy is a prescription medicine that can help people living with overweight or obesity lose weight in an effective and safe way. It is important to understand how Wegovy works, who may benefit from the treatment, and how the medicine affects weight loss and health. To make an informed decision about treatment with Wegovy, it is essential to have access to accurate and sufficient information.
Semaglutide for weight loss – information about the medicine
An increasing number of people today are living with overweight or obesity. Semaglutide has become one of the most effective medical treatments to help many people lose weight (1).
Semaglutide was originally developed as a treatment for type 2 diabetes, but clinical trials showed significant weight loss. The medication Wegovy (semaglutide 2.4 mg) is currently approved for weight management in adults with a BMI ≥ 30, or ≥ 27 with weight-related comorbidity (2).
Are weight loss and fat loss the same thing?
Many people who want to improve their health talk about “losing weight” – but what does that actually mean? Is the goal to weigh less, or to have less body fat? The difference is crucial for both health and results. To choose the right strategy, you need to understand the distinction between weight loss and fat loss. Even though they may sound like the same thing, they have different effects on our bodies and our health.
